The Cooper Companies, Inc. vs West Pharmaceutical Services, I
A head-to-head of The Cooper Companies, Inc. (COO) and West Pharmaceutical Services, I (WST) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | COO | WST |
|---|---|---|
| Market Cap | $13.99B | $25.31B |
| P/E (TTM) | 60.77 | 47.79 |
| Forward P/E | 13.64 | 34.01 |
| P/S | 2.96 | 6.48 |
| P/B | 1.90 | 8.67 |
| EV/EBITDA | 13.78 | 24.06 |
| Dividend Yield | — | 0.24% |
| Profit Margin | 5.57% | 16.85% |
| Gross Margin | 65.54% | 35.89% |
| Operating Margin | 16.69% | 20.09% |
| Revenue Growth (YoY) | +7.90% | +21.01% |
| FCF Yield | 3.99% | 2.19% |
| Debt / Equity | 29.83 | 7.50 |
| Current Ratio | 1.27 | 2.71 |
Which is better: The Cooper Companies, Inc. or West Pharmaceutical Services, I?
- ✓Larger by market cap: West Pharmaceutical Services, I
- ✓Cheaper valuation (lower P/E): West Pharmaceutical Services, I
- ✓More profitable (net margin): West Pharmaceutical Services, I
- ✓Faster revenue growth: West Pharmaceutical Services, I
- ✓Higher free-cash-flow yield: The Cooper Companies, Inc.
Very close — each leads on 6 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.